[Automatic translation follows] INRAE, French National Research Institute for Agriculture, Food and the Environment INRAE, the French National Research Institute for Agriculture, Food and the Environment, is a major player in research and innovation created on January 1, 2020. A finalized research institute resulting from the merger between Inra and Irstea, INRAE ​​brings together a community of 12,000 people, with just over 200 research units and around forty experimental units located in 18 centers throughout France. The institute is positioned among the very first world leaders in agricultural and food sciences, plant and animal sciences, and ranks 11th worldwide in …

Sectors: Research

Pioneering Diagnostics Pioneering Diagnostics A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. …

Sectors: Biotechnology

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare

Tags: CAC40 Sectors: Pharmaceutical

[Automatic translation follows] #auvergnerhonealpes Auvergne-Rhône-Alpes is a large region with many assets: - With more than 8 million inhabitants, it is more populated than 13 of the 28 countries of the European Union and ranks 10th most populated region in Europe - Covering nearly 70,000 km2, or 13% of the metropolitan territory, its surface area is equivalent to that of Ireland. - In France, it is the leading industrial and gastronomic region, it ranks first for agricultural production under label (AOP, IGP, etc.) and the number of organic farms. - In Europe: it is the 8th richest region in Europe …

Sectors: National and local authorities

[Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Les Entreprises du médicament, brings together companies in the pharmaceutical industry sector in France. Created over 130 years ago, Leem now has nearly 270 member companies, which generate nearly 98% of the total turnover of pharmaceuticals in France. The pharmaceutical industry employs 100,000 people in over 150 professions, and has recruited 10,000 employees per year for the past 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in …

Sectors: Startup accelerator & VC

Engineering the extraordinary A global healthcare technology leader — boldly attacking the most challenging health problems facing humanity with innovations that transform lives.

Sectors: Pharmaceutical

[Automatic translation follows] Together, let's catalyze success Creating value by developing innovative and competitive solutions for industry at the confluence of chemistry, environment and energy, and radiating internationally from a strong regional base, such is the ambition of AXELERA, the Auvergne-Rhône-Alpes chemistry-environment competitiveness cluster, created in 2005 by ARKEMA, CNRS, ENGIE, IFP Energies nouvelles, SUEZ and SOLVAY. AXELERA brings together and coordinates industry, research and training players in chemistry and the environment, around 5 strategic axes: renewable raw materials, eco-efficient plant, materials and products for industrial sectors, recycling and recyclability, preservation and restoration of natural and urban spaces. Ranked among …

Sectors: French Cluster Public business cluster

Our people are our strength. And, together with over 53,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing

Sectors: Animal Health Pharmaceutical